Proveca Placement Announcement

Following a successful search, The RSA Group, a leading Life Sciences Executive Search firm, is pleased to announce the placement of Dr Daniel Margetson as Chief Research & Development Officer at Proveca, a specialist pharmaceutical company developing medicines to improve the lives of children with chronic conditions requiring long term drug treatment.  Daniel started his new position on 12th September 2022.

Daniel brings 25+ years of industry experience in pharmaceutical product development with a successful track record of driving programmes from drug product formulation to commercial manufacturing, registration, and launch.

In his new position as Chief Research & Development Officer, Daniel will bring a balance of strategic, commercial, and technical leadership to Proveca’s existing market while also bringing new products online, to maintain and strengthen Proveca’s industry leadership. Daniel will help to create a compelling commercial story, leading, inspiring, and developing the business through the next phase of growth, bringing additional strategic and commercial bandwidth to the Board, and driving shareholder value.

Dr Andy Theodorou, Senior Consultant at The RSA Group, commented, “It has been an absolute pleasure to partner with Dr Simon Bryson, CEO of Proveca, to ensure we attract a talented individual who shares his passion for developing medicines for children with difficult to treat chronic conditions. Daniel’s experience developing paediatric medicines will be of great value to his new role at Proveca. He understands the development and regulatory challenges, as well as the commercial risks and opportunities’’.

 

ENDS

 

For further information, contact: 

Sandy Chadwick

Head of Global Marketing, The RSA Group

E:   Sandy.Chadwick@theRSAgroup.com

 

Notes to Editors

About The RSA Group
Founded in 1981, we are the pre-eminent global executive search firm in Life Sciences and Healthcare. We provide a unique combination of Executive Search and Executive Interims from Director to Board Level.  In addition to supporting clients with market due diligence, competitor benchmarking, and brand perception surveys, we also review organisations as part of our People & Organisation Advisory and recommend the best options for evolution across organisational design, talent acquisition, development, and succession planning. With offices globally, we offer clients and candidates alike our in-depth knowledge and understanding of the life sciences industry, as well as first class project execution.  To learn more about The RSA Group, visit www.theRSAgroup.com.

Share this: